BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Kaleido Biosciences Adds Two Senior Leaders to Guide Next Phase of Growth

  Kaleido Biosciences announced today the appointment of John W. Davies, Ph.D. as chief technology officer and Michael D. Bruce, Ph.D. as senior vice president, project, portfolio and alliance management.

  November 1, 2017

   · 

  3 min read
• BioCapital

  Sekisui Diagnostics Selects Ginolis for Automated Production Solution

  Sekisui Diagnostics has selected global automation solutions provider, Ginolis, to automate the packaging and labeling of its rapid diagnostic test strips

  November 1, 2017

   · 

  2 min read
• Deals

  Angle PLC: Completion of Fundraising and Acquisition

  ANGLE plc, a world-leading liquid biopsy company, is pleased to announce that further to the announcement of 30 October 2017 and General Admission earlier today, the Fundraising and Acquisition of certain assets of Axela Inc. is now complete.

  November 1, 2017

   · 

  3 min read
• Business

  Theravance Biopharma Announces Opening of Company’s New Corporate Office in Dublin, Ireland

  Theravance today announced the opening of a new corporate office in Dublin, further establishing the Company’s presence in Ireland.

  November 1, 2017

   · 

  6 min read
• Business

  Galmed Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 9th

  Galmed Pharma today announced that it will host a conference call and webcast to discuss results for the three and nine months ended September 30, 2017 and to provide an update on current developments with respect to its clinical programs for Aramchol on Thursday, November 9, 2017.

  November 1, 2017

   · 

  5 min read
• Business

  Halyard Health Announces Third Quarter 2017 Results, Raises Full-Year Adjusted Diluted EPS Outlook

  Third quarter 2017 net sales totaled $401M, compared to $398M in the same period last year.

  November 1, 2017

   · 

  41 min read
• Business

  RXi Pharmaceuticals to Webcast Third Quarter 2017 Financial Results on Wednesday, November 8, 2017

  RXi Pharma today announced that it will report its financial results for the third quarter ended September 30, 2017, and provide a business update on Wednesday, November 8, 2017 after the close of the U.S. financial markets.

  November 1, 2017

   · 

  3 min read
• Drug Development

  FDA Grants Rare Pediatric Disease Designation to ArQule’s Miransertib (ARQ 092) for the Treatment of Proteus Syndrome

  Miransertib is an orally available, selective pan-AKT inhibitor.

  November 1, 2017

   · 

  8 min read
• Business

  Bristol-Myers Squibb, BioLabs Announce Founding Sponsorship in Support of Promising Biotech Companies in New York

  As part of the agreement, for each year of active sponsorship, Bristol-Myers Squibb can nominate up to three innovative life-sciences and biotech startup companies per year to take up residence in BioLabs’ facilities at 180 Varick Street in Manhattan.

  November 1, 2017

   · 

  4 min read
• Business

  Owens & Minor Reports 3rd Quarter 2017 Financial Results

  Consolidated operating earnings for the third quarter of 2017 were $29.7 million, compared to $53.6 million in last year’s third quarter.

  November 1, 2017

   · 

  22 min read